Rosetta Genomics Ltd. provided earnings guidance for the six months ended June 30, 2015. The company is working to facilitate the completion and submission of its financial statements, and expects to do so on or before October 28, 2015 and expects to report unaudited pro forma revenue for the six months ended June 30, 2015 of approximately $4.0 million at that time.